Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:02:06.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a significant update in the study record related to the evaluation of risankizumab for the treatment of moderate to severe atopic dermatitis in adults and adolescents.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:25.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that researchers are looking for adults and adolescents with a diagnosis of atopic dermatitis. Previously, this section only indicated that no information was provided about collaborators.
    Difference
    9%
    Check dated 2024-05-22T20:53:34.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T23:27:44.000Z thumbnail image

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.